DCUN1D5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.570400E-01
Normal-vs-Stage2
6.828400E-01
Normal-vs-Stage3
8.974400E-01
Normal-vs-Stage4
2.554200E-01
Stage1-vs-Stage2
5.800200E-01
Stage1-vs-Stage3
9.795400E-01
Stage1-vs-Stage4
3.194600E-01
Stage2-vs-Stage3
8.857400E-01
Stage2-vs-Stage4
1.470760E-01
Stage3-vs-Stage4
5.264000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.896800E-01
Normal-vs-AfricanAmerican
5.382400E-01
Normal-vs-Asian
4.153000E-01
Caucasian-vs-AfricanAmerican
7.802000E-01
Caucasian-vs-Asian
1.754970E-01
AfricanAmerican-vs-Asian
8.393700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.166600E-01
Normal-vs-Female
5.039400E-01
Male-vs-Female
3.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.151800E-01
Normal-vs-Age(41-60Yrs)
2.709000E-01
Normal-vs-Age(61-80Yrs)
6.261800E-01
Normal-vs-Age(81-100Yrs)
9.013400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.276000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.978400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.671600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.402770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.490800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.357200E-01
Normal-vs-Daily Drinker
6.054600E-01
Normal-vs-Weekly Drinker
3.898000E-01
Normal-vs-Occasional Drinker
8.954800E-01
Normal-vs-Social Drinker
2.087200E-01
Non Drinker-vs-Daily Drinker
6.624400E-01
Non Drinker-vs-Weekly Drinker
3.625200E-01
Non Drinker-vs-Occasional Drinker
5.045600E-01
Non Drinker-vs-Social Drinker
3.556600E-01
Daily Drinker-vs-Weekly Drinker
3.381200E-01
Daily Drinker-vs-Occasional Drinker
2.734000E-01
Daily Drinker-vs-Social Drinker
6.559000E-01
Weekly Drinker-vs-Occasional Drinker
4.107400E-01
Weekly Drinker-vs-Social Drinker
3.197200E-01
Occasional Drinker-vs-Social Drinker
1.457000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.201600E-01
Normal-vs-Grade 2
5.260600E-01
Normal-vs-Grade 3
5.301000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.979800E-02
Grade 1-vs-Grade 3
8.216200E-03
Grade 1-vs-Grade 4
5.201600E-01
Grade 2-vs-Grade 3
2.287200E-01
Grade 2-vs-Grade 4
5.260600E-01
Grade 3-vs-Grade 4
5.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.892600E-01
Normal-vs-NonDiabetic
6.253800E-01
Diabetic-vs-NonDiabetic
3.515400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.529400E-01
Normal-vs-NoPancreatitis
7.847800E-01
Pancreatitis-vs-NoPancreatitis
4.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.500000E-01
Normal-vs-N1
6.203600E-01
N0-vs-N1
4.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.552600E-01
Normal-vs-TP53-NonMutant
3.767000E-01
TP53-Mutant-vs-TP53-NonMutant
6.999900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
